Food allergies are a major health problem in the US with an estimated 11 million Americans afflicted. Peanut allergy, which affects over 1.5 million Americans, is the single leading cause of severe and fatal food-induced allergic reactions. The prevalence of peanut allergy in children has doubled since the mid-1990's, and eosinophilic esophagitis (EE), largely food-related in children, has also markedly increased in prevalence. The current standard of care for managing food allergies consists of educating patients about food allergen avoidance and initiating therapy in case of an accidental ingestion. This approach is clearly inadequate since food allergic reactions are the leading single leading cause of anaphylaxis treated in US emergency departments, and dietary management of EE is extremely difficult and often ineffective. Recent oral immunotherapy trials suggest new approaches may alter the course of these disorders. A Consortium of investigators from five universities was formed to address this problem: Mount Sinai, Johns Hopkins, Duke, Arkansas, and National Jewish Health. The main objectives of this Consortium were to investigate the natural history of milk, egg and peanut allergy in infants, delineate underlying immunologic parameters associated with the natural course of milk and egg tolerance and peanut sensitization, and Identify biological markers that distinguish young children likely to develop symptomatic peanut allergy;and to test novel immunotherapies for the treatment of food allergy and delineate responsible mechanisms. The highly successful Consortium has recruited and retained a large cohort of children at high risk to develop peanut allergy, initiated three novel therapeutic trials, and been investigating immunologic mechanisms associated with the development and natural history of food allergy and immunotherapy. The Consortium proposed here will extend ongoing studies on the previous observational cohort and peanut SLIT trial, evaluate the efficacy of two novel immunotherapeutic approaches, and with the addition of a new site at Cincinatti Children's Hospital, initiate studies on the role of food allergy in EE, comparing and contrasting natural history and immunologic and genetic markers of EE with those of IgE-mediated food allergy.

Public Health Relevance

Food allergy and eosinophilic esophagitis, a food-related disorder, are affecting increasing numbers of Americans. Our five university consortium has effectively begun to address the underlying immunology of IgE-mediated food allergy and its treatment, and seeks to expand this effort by monitoring our well established cohort, evaluating other novel therapeutic strategies and investigating a growing and poorly understood food-related disorder, eosinophilic esophagitis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI066738-09
Application #
8505356
Study Section
Special Emphasis Panel (ZAI1-WFD-I (M3))
Program Officer
Minnicozzi, Michael
Project Start
2005-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$4,291,494
Indirect Cost
$990,525
Name
Icahn School of Medicine at Mount Sinai
Department
Pediatrics
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Caubet, Jean-Christoph; Masilamani, Madhan; Rivers, Neisha A et al. (2014) Potential non-T cells source of interleukin-4 in food allergy. Pediatr Allergy Immunol 25:243-9
Jung, YunJae; Rothenberg, Marc E (2014) Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol 193:999-1005
Kottyan, Leah C; Davis, Benjamin P; Sherrill, Joseph D et al. (2014) Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 46:895-900
Lim, Eunjin; Rothenberg, Marc E (2014) Demethylation of the human eotaxin-3 gene promoter leads to the elevated expression of eotaxin-3. J Immunol 192:466-74
Sherrill, Joseph D; Rothenberg, Marc E (2014) Genetic and epigenetic underpinnings of eosinophilic esophagitis. Gastroenterol Clin North Am 43:269-80
Jarvinen, K M; Westfall, J E; Seppo, M S et al. (2014) Role of maternal elimination diets and human milk IgA in the development of cow's milk allergy in the infants. Clin Exp Allergy 44:69-78
Sicherer, Scott H; Wood, Robert A; Vickery, Brian P et al. (2014) The natural history of egg allergy in an observational cohort. J Allergy Clin Immunol 133:492-9
Fleischer, David M; Burks, A Wesley; Vickery, Brian P et al. (2013) Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 131:119-27.e1-7
Wood, R A; Sicherer, S H; Burks, A W et al. (2013) A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy 68:803-8
Wood, Robert A; Sicherer, Scott H; Vickery, Brian P et al. (2013) The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol 131:805-12

Showing the most recent 10 out of 35 publications